UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

COVID-19 and myocarditis: a systematic review and overview of current challenges

Heart failure reviews, 2022-01, Vol.27 (1), p.251-261

2022

Volltextzugriff (PDF)

Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies

European Journal of Preventive Cardiology, 2020-03, Vol.27 (5), p.494-510

2020

Volltextzugriff (PDF)

CRISPR-Cas9 for the Treatment of Transthyretin Cardiac Amyloidosis

Current pharmaceutical design, 2023-01, Vol.29 (39), p.3166-3169

2023

Volltextzugriff (PDF)

Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies

European journal of heart failure, 2022-12, Vol.24 (12), p.2342-2351

2022

Volltextzugriff (PDF)

Predictors of adverse prognosis in COVID‐19: A systematic review and meta‐analysis

European journal of clinical investigation, 2020-10, Vol.50 (10), p.e13362-n/a

2020

Volltextzugriff (PDF)

Treatment of cardiac transthyretin amyloidosis: an update

European heart journal, 2019-12, Vol.40 (45), p.3699-3706

2019

Volltextzugriff (PDF)

Myocardial perfusion years after radiation therapy for left-sided breast cancer: Normal or abnormal? This is the question

Journal of nuclear cardiology, 2021-10, Vol.28 (5), p.1933-1935

2021

Volltextzugriff (PDF)

Cardiovascular risk evaluation in pregnancy: focus on cardiac specific biomarkers

Clinical chemistry and laboratory medicine, 2024-03, Vol.62 (4), p.581-592

2024

Volltextzugriff (PDF)

Inflammageing and Cardiovascular System: Focus on Cardiokines and Cardiac-Specific Biomarkers

International journal of molecular sciences, 2023-01, Vol.24 (1), p.844

2023

Volltextzugriff (PDF)

Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis

European journal of internal medicine, 2020-10, Vol.80, p.66-72

2020

Volltextzugriff (PDF)

Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence

Pharmacological research, 2020-05, Vol.155, p.104694, Article 104694

2020

Volltextzugriff (PDF)

Use of biomarkers to diagnose and manage cardiac amyloidosis

European journal of heart failure, 2021-02, Vol.23 (2), p.217-230

2021

Volltextzugriff (PDF)

Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis

Cardiovascular drugs and therapy, 2021-10, Vol.35 (5), p.1067-1076

2021

Volltextzugriff (PDF)

Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis

PloS one, 2022-01, Vol.17 (1), p.e0261986-e0261986

2022

Volltextzugriff (PDF)

Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets

Heart failure reviews, 2021-07, Vol.26 (4), p.881-890

2021

Volltextzugriff (PDF)

The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target?

International journal of cardiology, 2018-09, Vol.267, p.188-192

2018

Volltextzugriff (PDF)

Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis

Scientific reports, 2022-03, Vol.12 (1), p.4691-4691, Article 4691

2022

Volltextzugriff (PDF)

Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance

Journal of cardiovascular magnetic resonance, 2020-12, Vol.22 (1), p.84-84, Article 84

2020

Volltextzugriff (PDF)

The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease

European journal of heart failure, 2021-09, Vol.23 (9), p.1458-1467

2021

Volltextzugriff (PDF)

Prognostic value of right ventricular native T1 mapping in pulmonary arterial hypertension

PloS one, 2021-11, Vol.16 (11), p.e0260456

2021

Volltextzugriff (PDF)

Measurement of Cardiac-Specific Biomarkers in the Emergency Department: New Insight in Risk Evaluation

International journal of molecular sciences, 2023-11, Vol.24 (21), p.15998

2023

Volltextzugriff (PDF)

Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction

Heart failure reviews, 2022, Vol.27 (1), p.191-205

2022

Volltextzugriff (PDF)

In silico trial of baroreflex activation therapy for the treatment of obesity-induced hypertension

PloS one, 2021-11, Vol.16 (11), p.e0259917-e0259917

2021

Volltextzugriff (PDF)

Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis

Clinical research in cardiology, 2021-11, Vol.110 (11), p.1697-1703

2021

Volltextzugriff (PDF)

1 – 25 von 451

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(419)
Mit Volltextzugriff
(368)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(318)
Life Sciences & Biomedicine
(307)
Cardiovascular System & Cardiology
(238)
Cardiac & Cardiovascular Systems
(236)
Humans
(152)
Heart Failure
(94)
Prognosis
(52)
Male
(47)
Female
(45)
Biomarkers
(44)
Cardiology
(40)
Medicine
(35)
Aged
(33)
Amyloidosis
(32)
Heart
(32)
General & Internal Medicine
(29)
Medicine, General & Internal
(29)
Cardiac Amyloidosis
(26)
Patients
(26)
Diagnosis
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

COVID-19 and myocarditis: a systematic review and overview of current challenges

Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies

CRISPR-Cas9 for the Treatment of Transthyretin Cardiac Amyloidosis

Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies

Predictors of adverse prognosis in COVID‐19: A systematic review and meta‐analysis

Treatment of cardiac transthyretin amyloidosis: an update

Myocardial perfusion years after radiation therapy for left-sided breast cancer: Normal or abnormal? This is the question

Cardiovascular risk evaluation in pregnancy: focus on cardiac specific biomarkers

Inflammageing and Cardiovascular System: Focus on Cardiokines and Cardiac-Specific Biomarkers

Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis

Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence

Use of biomarkers to diagnose and manage cardiac amyloidosis

Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis

Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis

Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis

Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets

The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target?

Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis

Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance

The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease

Prognostic value of right ventricular native T1 mapping in pulmonary arterial hypertension

Measurement of Cardiac-Specific Biomarkers in the Emergency Department: New Insight in Risk Evaluation

Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction

In silico trial of baroreflex activation therapy for the treatment of obesity-induced hypertension

Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis

Suchergebnisse filtern